This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Perspective Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Daniel McAlister
Introduction
Daniel McAlister is an accomplished inventor based in Downers Grove, IL. He has made significant contributions to the field of radioisotope separation, particularly through his innovative patent. His work is essential for advancements in medical applications and radiopharmaceuticals.
Latest Patents
Daniel McAlister holds a patent for "Systems and methods for generating lead." This patent describes a method for separating a lead radioisotope from a mixture that includes radium or thorium radioisotopes. The system comprises multiple chromatographic columns, including a first cartridge with lead-complexing media that preferentially binds the lead radioisotope. Additionally, it features a second cartridge with weak cationic exchange media, which operates under specific pH conditions to elute the lead radioisotope. This innovative system aims to provide a purified solution of lead radioisotope for medical and other applications.
Career Highlights
Daniel McAlister is currently employed at Perspective Therapeutics, Inc., where he continues to develop and refine his innovative technologies. His work is pivotal in enhancing the efficiency and effectiveness of radioisotope separation processes.
Collaborations
Daniel collaborates with notable colleagues, including Edwin A. Sagastume and Michael K. Schultz. Their combined expertise contributes to the advancement of technologies in the field of radiopharmaceuticals.
Conclusion
Daniel McAlister's contributions to the field of radioisotope separation are noteworthy and impactful. His innovative patent and ongoing work at Perspective Therapeutics, Inc. highlight his commitment to advancing medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile